News & Updates

Show Multimedia Only

Mediterranean–DASH diet improves health outcomes in T2D, hypertension

22 Sep 2025

Adherence to the Mediterranean–Dietary Approaches to Stop Hypertension (DASH) diet leads to improvements in anthropometric, laboratory parameters, and blood pressure (BP) in patients with type 2 diabetes (T2D) and hypertension, reports a study. This intervention also improves satiety levels throughout the day.

Mediterranean–DASH diet improves health outcomes in T2D, hypertension

22 Sep 2025

Semaglutide works well for Asians with obesity

22 Sep 2025

Once-weekly treatment with semaglutide is safe and induces weight loss in Asians with obesity, according to the phase III STEP 11 trial.

Semaglutide works well for Asians with obesity

22 Sep 2025

GLP-1 RAs work well for managing T2D, obesity in children

21 Sep 2025 by

Children and teens with type 2 diabetes (T2D) or obesity benefit from glucagon-like peptide-1 receptor agonists (GLP-1RAs), which help improve blood sugar and weight, according to a meta-analysis.

GLP-1 RAs work well for managing T2D, obesity in children

21 Sep 2025

Statins may protect adults with T1DM against all-cause death, CVD

19 Sep 2025

The use of statins for primary prevention in adults with type 1 diabetes mellitus (T1DM) appears to prevent all-cause mortality and major cardiovascular disease (CVD), with an acceptable safety profile, a study has shown.

Statins may protect adults with T1DM against all-cause death, CVD

19 Sep 2025

Optimal glycaemic control associated with lower pancreatic cancer risk in T2D

19 Sep 2025 by

In patients with type 2 diabetes (T2D), optimal glycaemic control is associated with lower risks of pancreatic cancer as well as pancreatic cancer–related mortality and all-cause mortality, a territory-wide population-based retrospective cohort study has shown.

Optimal glycaemic control associated with lower pancreatic cancer risk in T2D

19 Sep 2025

Nutrition content on TikTok: Reliable or not?

18 Sep 2025 by

A cross-sectional study shows that nutrition-related content from TikTok is heavily influenced by non-expert creators and diet culture, with misleading content often receiving higher engagement than credible information.

Nutrition content on TikTok: Reliable or not?

18 Sep 2025

LTSG delivers durable weight loss, improves metabolic syndrome

18 Sep 2025

Simultaneous liver transplantation (LT) and sleeve gastrectomy (SG) is effective in sustaining weight loss, managing diabetes and hypertension, and preventing recurrence of steatosis and possibly fibrosis compared with LT alone, suggests a study.

LTSG delivers durable weight loss, improves metabolic syndrome

18 Sep 2025

Transforming Obesity Care: Insights from Experts on Semaglutide 2.4 mg

18 Sep 2025

With the launch of semaglutide 2.4 mg (Wegovy) in Singapore, a new chapter in the pharmacological treatment of obesity begins. MIMS Doctor spoke with two leading experts: Professor David Lau, an endocrinologist and Professor Emeritus of Medicine at the University of Calgary Cumming School of Medicine, Canada, and a key contributor to the 2020 Canadian Adult Obesity Guidelines, and Dr Georgia Rigas, Senior Bariatric Medical Practitioner at St George Private Hospital, Sydney, Australia, with extensive experience in primary care obesity management. Both experts shared compelling insights on how semaglutide 2.4 mg is set to transform obesity care across clinical settings.

Transforming Obesity Care: Insights from Experts on Semaglutide 2.4 mg

18 Sep 2025

Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity

17 Sep 2025 by

Patients with heart failure (HF) with preserved ejection fraction (HFpEF), obesity, and type 2 diabetes (T2D) show a favourable response to tirzepatide despite less pronounced weight loss, reports a study.

Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity

17 Sep 2025

Screen time in kids, teens tied to cardiometabolic and cardiovascular risks

17 Sep 2025 by

A study using data from two Danish cohorts demonstrates an association between cardiometabolic risk (CMR) and cardiovascular risk (CVR) and screen time (ST) in children and adolescents, be it through phone, television, or gaming.

Screen time in kids, teens tied to cardiometabolic and cardiovascular risks

17 Sep 2025

News & Updates

Filter by Specialty:

Specialty:

Mediterranean–DASH diet improves health outcomes in T2D, hypertension

Mediterranean–DASH diet improves health outcomes in T2D, hypertension

Semaglutide works well for Asians with obesity

Semaglutide works well for Asians with obesity

GLP-1 RAs work well for managing T2D, obesity in children

GLP-1 RAs work well for managing T2D, obesity in children

Statins may protect adults with T1DM against all-cause death, CVD

Statins may protect adults with T1DM against all-cause death, CVD

Optimal glycaemic control associated with lower pancreatic cancer risk in T2D

Optimal glycaemic control associated with lower pancreatic cancer risk in T2D

Nutrition content on TikTok: Reliable or not?

Nutrition content on TikTok: Reliable or not?

LTSG delivers durable weight loss, improves metabolic syndrome

LTSG delivers durable weight loss, improves metabolic syndrome

Transforming Obesity Care: Insights from Experts on Semaglutide 2.4 mg

Transforming Obesity Care: Insights from Experts on Semaglutide 2.4 mg

Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity

Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity

Screen time in kids, teens tied to cardiometabolic and cardiovascular risks

Screen time in kids, teens tied to cardiometabolic and cardiovascular risks